CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy

Stine Sofie Frank Lende, Marie Høst Pahus, Ida Monrad, Rikke Olesen, Anna R. Mahr, Line K. Vibholm, Lars Østergaard, Ole Schmeltz Søgaard, Anna Halling Folkmar Andersen, Paul W. Denton, Martin Tolstrup

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences